In cases of transgenic mice displaying a phenotype due to insertional mutagenesis, it is often desirable to clone out the site of transgene integration and to identify the disrupted endogenous gene. Here we report modifications to an existing genomic cloning method that provide a powerful and rapid technique specifically tailored for cloning out transgene insertion sites. These modifications are designed to favor the amplification of bona fide integration sites over internal transgene fragments and are not dependant on prior knowledge of potentially complex transgene rearrangements. When combined with the mouse genome databases now available, this permits the rapid identification of genes inactivated via insertional mutagenesis.
Transgenic mouse lines harboring insertional mutations represent a valuable resource for correlating gene structure with gene function (5, 7, 12) . Cloning the site of transgene insertion has traditionally been an arduous endeavor, involving the creation of a genomic library of mutant mouse DNA usually in lambda phage, and the screening of the library with a labeled probe corresponding to the transgene used. These methods are now supplemented by PCR-based amplification techniques developed to generate flanking genomic DNA sequences (1, 2, 4, (8) (9) (10) (11) 13, 14) . Once the integration site is identified, extensive genomic sequencing of normal mouse DNA is still required to identify regional exons and candidate genes to account for mutant phenotypes.
In the present studies, transgenic mice were generated via conventional pronuclear microinjection. Two transgenes were co-injected, including the transgene of interest for the biological studies undertaken and a tyrosinase minigene used as a visual pigmentation marker for transgenesis (6) . A founder (F0) animal was identified by the presence of pigmentation and by PCR analysis for the transgene of interest; analysis of F1 animals revealed that the transgene of interest and the tyrosinase minigene co-segregated in an autosomal fashion, indicating a single transgene integration site incorporating both transgenes. When F2 homozygous animals were generated, a phenotype involving a mild neuromuscular deficit (trembling) was observed, indicating the possibility of an insertional mutation. These trembling animals were confirmed homozygote recessive by backcross breeding trials. Fluorescent in situ hybridization (FISH) using labeled transgenes was then performed on metaphase spreads of splenocytes taken from trembling animals. These studies confirmed that the animals were homozygote for transgene insertion and identified the site of insertion as mouse chromosome 6 region C (data not shown).
It was decided to clone out the genomic site of transgene integration, adapting the Universal GenomeWalker DNA cloning kit (BD Biosciences Clontech, San Jose, CA, USA) for this purpose. DNA was extracted from spleen and kidneys of a mouse homozygous for the transgenes using standard methods. Enzymes for genomic DNA digestions were chosen such that they did not cut within the transgenes used to generate the transgenic mice. Genomic DNA (2.5 µg) was digested separately with EcoRI, KpnI, MluI, NheI, SacII, SalI, SpeI, and SphII. Because the restriction enzymes chosen did not cut in a blunt fashion, an additional step to the provided protocol was performed, to blunt the genomic fragments before the adaptor ligation step. Genomic DNA digests were incubated with 1 µL Klenow DNA polymerase I (USB, Cleveland, OH, USA) and 1.5 µL 25 mM dNTPs for 1 h at 37°C. Purification of the digested, blunted genomic DNA and ligation to the GenomeWalker adaptor were then performed according to the user manual. The rationale for specific primer design is as follows. With two transgenes involved, four possible transgene orientations at the site of transgene integration are possible. Specific primers representing three of these possibilities were designed and synthesized, including sense primers from the 3′ end of the tyrosinase minigene (TyrosinaseWalk.A, 5′-AGCCACTCCTCATGGACAAAG-ACGACTA-3′, and TyrosinaseWalk.B, 5′-ACAGCTTGCTGTATCAGAGCC-ATCTGT-3′). In addition, 3′-sense and 5′-antisense primers from the transgene of interest were also designed but are not presented. PCR and nested PCR were performed as described in GenomeWalker kit user manual. The results obtained using primers TyrosinaseWalk.A and AP1 for the first PCR and TyrosinaseWalk.B and AP2 for the nested PCR are shown in Figure 1 . Four out of eight restriction mini-libraries generated identifiable bands suitable for cloning. Bands for EcoRI nested PCR, NheI primary PCR, and SacII nested PCR were subcloned into the pGEM-T ® vector (Promega, Madison, WI, USA), whereas bands for the SpeI PCRs were judged relatively small compared to other bands and were not subcloned. In total, six unique bands were sequenced, and the sequences were blasted with the Ensembl mouse genome data. Sequences of two amplified bands, from the NheI and SacII restricted minilibraries, co-localized to genomic sequences within Chr. 7E, representing the endogenous tyrosinase gene locus. Sequences of four amplified bands, two each from the SacII and EcoRI restricted mini-libraries, co-localized to genomic sequences located at Chr. 6C1 and represented one flank of the transgene integration site. Interestingly, the SacII restricted mini-library was able to identify both the endogenous tyrosinase genomic locus and the transgene insertion site. A more detailed analysis of the transgene integration site at Chr. 6C1 showed that the flanking sequences are located within intron 1 of the Grid2 gene (Figure 2) , thus providing an explanation for the trembling phenotype seen in the homozygote recessive animals (3). As a functional confirmation, RT-PCR studies on RNA extracted from the cerebellum of mice displaying the trembling phenotype failed to show evidence for Grid2 gene expression, whereas similar analysis on non-trembling (heterozygote) transgenic littermates and on non-transgenic control mice generated an amplified band of the predicted size (data not shown).
Two important modifications to the original Universal GenomeWalker kit protocol were made to accommodate the particularities of transgenic integration sites generated from pronuclear microinjection. We were able to show that the choice of the enzyme is not limited to those that cut in a blunt fashion, although DNA fragments with 5′ or 3′ overhangs must be subsequently rendered blunt. This allows freedom of choice of restriction enzymes by avoiding enzymes that cut within the transgene. This in turn provides the decided advantage of a method that favors informative amplifications at the site of transgene integration and disfavors noninformative amplifications from within the transgenes themselves. The second modification is the design of specific primers, where because of our two transgene co-injection strategy, four pairs of specific primers were designed for the PCR and nested PCR amplifications. By performing the amplification, cloning, and sequencing steps sequentially, we were able to identify the integration site after using three of these primer sets.
In conclusion, the Universal GenomeWalker Kit protocol is robust and easily adapted for deriving genomic flanking sequences at the site of transgene integration after pronuclear microinjection in mice. This, in combination with the mouse genome resources now available, such as Ensembl, provides a powerful and rapid system for identifying disrupted genes in the study of mouse transgene insertional mutagenesis. We are using bacteriophage λ as an efficient vector for transferring genomic alterations to embryonic stem (ES) cells via gene targeting. We have developed a variety of phage-plasmid recombination techniques to direct mutations and modification cassettes to specific sites within phage targeting vectors (1, (6) (7) (8) (9) . We have also made improvements on Seed's original method of recombination screening of bacteriophage libraries (5) , which allows phage clones to be isolated "genetically" using recombination. In retro-recombination screening (8), phage targeting vectors from an ES cell targeting vector library in λ thymidine kinase (TK) are purified on a restrictive host, following the homologous integration of a supF-homology-bearing plasmid, which suppresses A am , B am , and S am mutations in suitable phage λ genes essential for phage growth. Because the region of homology is duplicated upon integration, and can therefore revert under relaxed conditions (i.e., within a supF host), we incorporated the gam gene into the recombination plasmid to select for phages that have reverted to their original configuration (8) . Retro-recombination screening has several advantages over conventional phage library screening techniques. Specific targeting vector phages can be isolated without plaque hybridization and purified in 2-3 days to serve as templates for the rapid completion of targeting vector construction via recombination. Libraries are screened in culture tubes, meaning that multiple library screens (i.e., targeting vector homology region isolation) can be performed at one time and there is no shortage of the number of phages that can be screened simultaneously to ensure the isolation of distinct clones from the locus of interest. This latter point is particularly important in the case of our λTK library because the insert size is approximately 12 kb and as many as 2 × 10 6 phages need to be screened at one time to ensure sufficient representation of all genes within the library.
One drawback of recombination screening approaches is that most libraries, including our λTK library, are constructed with commercial packaging extracts that are not irradiated when prepared. As a result, a small yet significant number of non-amber phages can appear in a library of amber mutationcontaining phages, which arise from recombination between the two mutant strains used to generate head and tail extracts. While the incidence of such phages is rare (i.e., 10 -4 ), it presents a unique challenge in screening amplified libraries by recombination, as Following recombination screens, lysates were titered for blue (recombinant), white (non-amber), and total pfus. The frequency of recombination is presented as the number of blue plaques/total titer. *1G7 was precipitated from a 400-mL culture using PEG and resuspended in a final volume of 0.4 mL. For 1G7, recombinant plaques were determined using DK21. For all others, recombinant plaques were determined using LG75. Non-amber phages were identified as white plaques on LG75. Total titers were determined using LE392.
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